IOL Chemicals and Pharmaceuticals Limited
NSE:IOLCP.NS
398.15 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 21,327.9 | 22,171.1 | 21,683.7 | 19,461.4 | 18,635.1 | 16,550.2 | 9,621.4 | 7,106.531 | 5,804.153 | 3,847.253 | 5,635.013 | 4,815.11 | 4,706.826 | 3,894.074 | 3,494.203 | 3,018.585 | 3,179.429 | 2,025.94 |
Cost of Revenue
| 16,608.8 | 15,470.9 | 15,966.6 | 11,241.7 | 10,846.5 | 10,669.5 | 7,115.2 | 4,908.437 | 4,136.044 | 2,792.279 | 3,699.25 | 2,999.78 | 2,999.521 | 2,833.513 | 2,816.628 | 2,477.546 | 2,576.603 | 1,715.949 |
Gross Profit
| 4,719.1 | 6,700.2 | 5,717.1 | 8,219.7 | 7,788.6 | 5,880.7 | 2,506.2 | 2,198.094 | 1,668.109 | 1,054.974 | 1,935.763 | 1,815.33 | 1,707.305 | 1,060.561 | 677.575 | 541.039 | 602.826 | 309.992 |
Gross Profit Ratio
| 0.221 | 0.302 | 0.264 | 0.422 | 0.418 | 0.355 | 0.26 | 0.309 | 0.287 | 0.274 | 0.344 | 0.377 | 0.363 | 0.272 | 0.194 | 0.179 | 0.19 | 0.153 |
Reseach & Development Expenses
| 151.6 | 167.5 | 111.4 | 74.7 | 67.6 | 58.7 | 32.9 | 29.6 | 10.903 | 14.111 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 66.9 | 58.3 | 45 | 40.5 | 24.4 | 14.6 | 10.1 | 9.307 | 7.13 | 248.189 | 0.541 | 0.447 | 0 | 45.401 | 38.798 | 36.127 | 28.303 | 20.649 |
Selling & Marketing Expenses
| 512.5 | 618.5 | 668.4 | 507.8 | 484.5 | 466.1 | 258.1 | 0 | 0 | 0.006 | 112.69 | 233.593 | 0 | 174.522 | 140.909 | 96.693 | 124.434 | 60.313 |
SG&A
| 3,042.3 | 676.8 | 713.4 | 548.3 | 508.9 | 480.7 | 268.2 | 9.307 | 7.13 | 248.195 | 398.305 | 234.04 | 0 | 219.923 | 179.707 | 132.82 | 152.737 | 80.962 |
Other Expenses
| 300.7 | 256.1 | 33.1 | 12.7 | 14.8 | 7.4 | 1,294.8 | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 | 1,237.343 | 382.241 | 202.655 | 148.047 | 128.571 | 66.397 |
Operating Expenses
| 3,042.3 | 4,905.1 | 3,555.2 | 2,688.3 | 2,406.3 | 2,107.8 | 1,563 | 1,477.665 | 1,450.478 | 1,231.151 | 1,294.461 | 1,238.48 | 1,237.343 | 602.164 | 382.362 | 280.866 | 308.561 | 156.469 |
Operating Income
| 1,676.8 | 1,801 | 2,161.2 | 5,530.7 | 5,381.6 | 3,772.2 | 908.5 | 54.774 | -385.502 | -754.38 | 50.823 | 29.584 | 469.961 | 458.397 | 295.213 | 260.172 | 294.265 | 153.523 |
Operating Income Ratio
| 0.079 | 0.081 | 0.1 | 0.284 | 0.289 | 0.228 | 0.094 | 0.008 | -0.066 | -0.196 | 0.009 | 0.006 | 0.1 | 0.118 | 0.084 | 0.086 | 0.093 | 0.076 |
Total Other Income Expenses Net
| 139.7 | 85.5 | 87.3 | 183.2 | -49.2 | -410.7 | -595.5 | -665.655 | -603.134 | -578.203 | -590.478 | -547.266 | -431.985 | -367.965 | -148.674 | -149.195 | -130.598 | -66.53 |
Income Before Tax
| 1,816.5 | 1,886.5 | 2,248.5 | 5,713.9 | 5,332.4 | 3,361.5 | 313 | 54.774 | -385.502 | -754.38 | 50.823 | 29.584 | 37.977 | 90.431 | 146.54 | 110.977 | 163.667 | 86.993 |
Income Before Tax Ratio
| 0.085 | 0.085 | 0.104 | 0.294 | 0.286 | 0.203 | 0.033 | 0.008 | -0.066 | -0.196 | 0.009 | 0.006 | 0.008 | 0.023 | 0.042 | 0.037 | 0.051 | 0.043 |
Income Tax Expense
| 472.2 | 495.1 | 571.8 | 1,268.3 | 1,719.5 | 994.5 | 36 | 12.499 | 14.756 | -87.873 | 17.829 | 13.698 | -9.556 | 28.639 | 46.38 | -15.965 | 40.033 | 11.485 |
Net Income
| 1,344.3 | 1,391.4 | 1,676.7 | 4,445.6 | 3,612.9 | 2,367 | 277 | 42.275 | -400.258 | -666.507 | 32.994 | 15.886 | 47.533 | 61.792 | 100.16 | 126.943 | 123.633 | 75.508 |
Net Income Ratio
| 0.063 | 0.063 | 0.077 | 0.228 | 0.194 | 0.143 | 0.029 | 0.006 | -0.069 | -0.173 | 0.006 | 0.003 | 0.01 | 0.016 | 0.029 | 0.042 | 0.039 | 0.037 |
EPS
| 22.9 | 23.7 | 28.56 | 76.21 | 63.51 | 42.11 | 4.93 | 0.83 | -7.6 | -16.72 | 1.21 | 0.61 | 1.85 | 2.52 | 4.69 | 8.18 | 10.26 | 9.18 |
EPS Diluted
| 22.9 | 23.7 | 28.56 | 76.21 | 63.38 | 42.11 | 4.93 | 0.83 | -7.6 | -16.63 | 1.21 | 0.61 | 1.83 | 2.52 | 4.68 | 7.87 | 7.6 | 9.18 |
EBITDA
| 2,305.9 | 2,512.8 | 2,855.4 | 6,113.4 | 5,849.9 | 4,152.7 | 1,210.6 | 860.526 | 366.358 | 75.45 | 957.395 | 890.591 | 709.322 | 696.025 | 395.325 | 360.189 | 367.54 | 188.35 |
EBITDA Ratio
| 0.108 | 0.113 | 0.132 | 0.314 | 0.314 | 0.251 | 0.126 | 0.121 | 0.063 | 0.02 | 0.17 | 0.185 | 0.151 | 0.179 | 0.113 | 0.119 | 0.116 | 0.093 |